Domestic first-in-class drug approvals

2025年我国批准的首创新药为11个，其中4个是我国自主研发的。

The figure above was extracted from this passage. If it does not match, the extraction is wrong and we want to know.

Published under CC BY 4.0. Attribute the original publisher; the citations below do that for you and link to this permanent record.

APA

National Healthcare Security Administration. (2025). 国家医疗保障局 医保动态 创新高！去年我国批准创新药76个 对外授权破千亿美元. Retrieved September 17, 2026, from https://www.nhsa.gov.cn/art/2026/1/18/art_14_19392.html. Via StatOrigin, https://statorigin.org/stat/stat_YNSMX436YHHD8Z81G9V98C62GK

Copy

MLA

National Healthcare Security Administration. "国家医疗保障局 医保动态 创新高！去年我国批准创新药76个 对外授权破千亿美元." 2025, https://www.nhsa.gov.cn/art/2026/1/18/art_14_19392.html. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_YNSMX436YHHD8Z81G9V98C62GK.

Copy

Chicago

National Healthcare Security Administration. "国家医疗保障局 医保动态 创新高！去年我国批准创新药76个 对外授权破千亿美元." 2025. https://www.nhsa.gov.cn/art/2026/1/18/art_14_19392.html. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_YNSMX436YHHD8Z81G9V98C62GK.

Copy

BibTeX

@misc{nhsa2025domestic8c62gk, author = {{National Healthcare Security Administration}}, title = {国家医疗保障局 医保动态 创新高！去年我国批准创新药76个 对外授权破千亿美元}, year = {2025}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_YNSMX436YHHD8Z81G9V98C62GK}, note = {Original source: https://www.nhsa.gov.cn/art/2026/1/18/art\_14\_19392.html. Accessed September 17, 2026.} }

Copy

Everything needed to check this number yourself, without taking our word for it.

Record last modified 17 September 2026. Value type: actual. Update cadence: annual. This page is permanently addressable at statorigin.org/stat/stat_YNSMX436YHHD8Z81G9V98C62GK.